{
  "question": "Folic acid metabolism is inhibited by :  a) Sulfonamides b) Methotrexate c) Nitrous oxide d) Trimethoprim e) 5â€“Flucytosine",
  "is_multi_choice": true,
  "correct_answer": "opb",
  "options": {
    "opa": "acd",
    "opb": "abd",
    "opc": "bde",
    "opd": "ace"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "causal_graph": {
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "knowledge_graph": {
    "nodes": [
      [
        "Methotrexate",
        "Hypertension, Pulmonary",
        "Dihydrofolate Reductase"
      ],
      [
        "Dihydrofolate Reductase",
        "Cells",
        "Virus",
        "Folate"
      ],
      [
        "Dihydrofolate Reductase",
        "Myeloma cell",
        "Virus",
        "Folate"
      ],
      [
        "Nitrous Oxide",
        "Pharmaceutical Preparations",
        "APP gene",
        "Vitamin B 12"
      ],
      [
        "Nitrous Oxide",
        "Pharmaceutical Preparations",
        "Alleles",
        "Vitamin B 12"
      ]
    ],
    "relationships": [
      [
        "TREATS",
        "ASSOCIATED_WITH"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ]
    ],
    "paths": [
      "(Methotrexate)-TREATS->(Hypertension, Pulmonary)-ASSOCIATED_WITH->(Dihydrofolate Reductase)",
      "(Dihydrofolate Reductase)-INTERACTS_WITH->(Cells)-LOCATION_OF->(Virus)-LOCATION_OF->(Folate)",
      "(Dihydrofolate Reductase)-INTERACTS_WITH->(Myeloma cell)-PART_OF->(Virus)-LOCATION_OF->(Folate)",
      "(Nitrous Oxide)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(APP gene)-INTERACTS_WITH->(Vitamin B 12)",
      "(Nitrous Oxide)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Alleles)-INTERACTS_WITH->(Vitamin B 12)"
    ]
  },
  "enhanced_graph": {
    "nodes": [],
    "relationships": [],
    "paths": [
      "(Nitrous Oxide)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(APP gene)-INTERACTS_WITH->(Vitamin B 12)",
      "(Nitrous Oxide)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Alleles)-INTERACTS_WITH->(Vitamin B 12)",
      "(Methotrexate)-TREATS->(Hypertension, Pulmonary)-ASSOCIATED_WITH->(Dihydrofolate Reductase)"
    ]
  },
  "reasoning_chain": [
    "CHAIN: \"Sulfonamides\" -> \"inhibit bacterial folate synthesis\" -> \"potentially affects human folate metabolism\" -> 70%",
    "CHAIN: \"Methotrexate\" -> \"inhibits dihydrofolate reductase\" -> \"reduces folate availability\" -> 95%",
    "CHAIN: \"Nitrous oxide\" -> \"inhibits vitamin B12 function\" -> \"may affect folate metabolism\" -> 60%",
    "CHAIN: \"Trimethoprim\" -> \"inhibits bacterial dihydrofolate reductase\" -> \"reduces folate synthesis in bacteria\" -> 80%",
    "CHAIN: \"5-Flucytosine\" -> \"inhibits fungal DNA synthesis\" -> \"does not directly affect folate metabolism\" -> 50%",
    "CHAIN: \"Sulfonamides\" -> \"inhibit folate synthesis\" -> \"affect folate metabolism\" -> 70% CHAIN: \"Methotrexate\" -> \"inhibits folate metabolism\" -> \"reduces folate levels\" -> 95% CHAIN: \"Nitrous oxide\" -> \"unclear effect on folate metabolism\" -> \"possible inhibition\" -> 50% CHAIN: \"Trimethoprim\" -> \"inhibits folate synthesis\" -> \"affects folate metabolism\" -> 80% CHAIN: \"5-Flucytosine\" -> \"does not inhibit folate metabolism\" -> \"no effect\" -> 70%",
    "CHAIN: Confidence in the overall assessment: -> 85%"
  ],
  "enhanced_information": "Folic acid metabolism is inhibited by agents that interfere with folate synthesis or function. Methotrexate is well-known to inhibit dihydrofolate reductase, directly reducing folate availability, which aligns with consensus and is supported by evidence paths linking it to dihydrofolate reductase. Sulfonamides inhibit bacterial folate synthesis, which can indirectly affect human folate metabolism, but their primary action is on bacteria, not directly on human folate metabolism. Trimethoprim also inhibits bacterial dihydrofolate reductase, affecting bacterial folate synthesis, but not directly human folate metabolism. Nitrous oxide affects vitamin B12 function, which can secondarily impact folate metabolism, but this is not a direct inhibition of folate metabolism. 5-Flucytosine primarily targets fungal DNA synthesis and does not directly inhibit folate metabolism. Therefore, the most consensus-aligned inhibitors of folate metabolism in humans are Methotrexate and, to a lesser extent, Nitrous Oxide due to its indirect effect through vitamin B12 interaction.",
  "analysis": "Folic acid metabolism can be inhibited by agents that interfere with folate synthesis or function. Methotrexate is a well-known inhibitor of dihydrofolate reductase, directly affecting folate metabolism. Sulfonamides and Trimethoprim primarily target bacterial folate synthesis, but they do not directly inhibit human folate metabolism. Nitrous oxide can indirectly affect folate metabolism by interfering with vitamin B12, which is necessary for folate function, but it is not a direct inhibitor. 5-Flucytosine targets fungal DNA synthesis and does not directly inhibit folate metabolism. Based on this understanding, Methotrexate and Nitrous Oxide are the most relevant inhibitors of folate metabolism in humans, with Methotrexate being the primary direct inhibitor. Therefore, the most likely correct answer is option 'opa', which includes Methotrexate and Nitrous Oxide.",
  "answer": "opa",
  "confidence": 85.0,
  "chain_coverage": {
    "success_counts": [
      0,
      2,
      1,
      0,
      0,
      0,
      0
    ],
    "coverage_rates": [
      0.0,
      66.66666666666666,
      33.33333333333333,
      0.0,
      0.0,
      0.0,
      0.0
    ],
    "total_successes": 3
  },
  "normal_results": []
}